**Author details**

Francesca Nicolo'1 \*, Antonio Lio1 , Marina Comisso1 , Romina Pantanella2 , Roberto Scrofani3 and Francesco Musumeci1

1 Department of Cardiac Surgery and Transplantation, S. Camillo Hospital, Rome, Italy

2 Department of Cardiac Surgery, Policlinico Sant'Andrea, Sapienza University, Rome, Italy

3 Department of Cardiac Surgery, L. Sacco Hospital, Milano, Italy

\*Address all correspondence to: nicolo\_francy84@hotmail.it

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**117**

*Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy*

practice guidelines. The Journal of Thoracic and Cardiovascular Surgery.

[8] Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic

[9] Messmer BJ. Extended myectomy

cardiomyopathy. The Annals of Thoracic

[10] Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive

cardiomyopathy. The Annals of Thoracic

[11] Maron BJ, Dearani JA, Ommen SR, et al. Low operative mortality achieved with surgical septal myectomy: Role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. Journal of the American College of Cardiology.

[12] Kim LK, Swaminathan RV, Looser P, et al. Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003- 2011. JAMA Cardiology. 2016;**1**:324-332

[13] Mohr R, Schaff HV, Puga FJ, Danielson GK. Results of operation for hypertrophic obstructive

cardiomyopathy in children and adults less than 40 years of age. Circulation.

[14] Maron BJ, Peterson EE, Maron MS,

hypertrophic cardiomyopathy in an

for hypertrophic obstructive

Surgery. 1994;**58**:575-577

Surgery. 2008;**85**:127-133

2015;**66**:1307-1308

1989;**80**:I191-I196

Peterson JE. Prevalence of

hypertrophic subaortic stenosis: Technic and hemodynamic results of subaortic ventriculomyotomy. Annals of Surgery.

2011;**142**:1303-1338

1961;**154**:181-189

*DOI: http://dx.doi.org/10.5772/intechopen.86816*

[1] Authors/Task Force Members, Elliott PM, Anastasakis A, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal.

[2] Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. Journal of the American College of Cardiology.

**References**

2014;**35**:2733-2779

2015;**65**:1249-1254

[3] Maron BJ. Sudden death in

[4] Prinz C, Farr M, Hering D, Horstkotte D, Faber L. The diagnosis and treatment of hypertrophic

[5] Nishimura RA, Seggewiss H, Schaff HV. Hypertrophic obstructive cardiomyopathy: Surgical myectomy and septal ablation. Circulation Research. 2017;**121**:771-783

of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional

1981;**48**:418-428

hypertrophic cardiomyopathy. Journal of Cardiovascular Translational Research. 2009;**2**:368-380

cardiomyopathy. Deutsches Ärzteblatt International. 2011;**108**:209-215

[6] Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution

echocardiographic study of 125 patients. The American Journal of Cardiology.

[7] Gersh BJ, Maron BJ, Bonow RO, et al. 2011 CCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American college of cardiology foundation/American heart association task force on

*Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy DOI: http://dx.doi.org/10.5772/intechopen.86816*
